Please provide your email address to receive an email when new articles are posted on . Researchers engaged in a secondary analysis of the ESCAPE clinical trial in patients with acute ischemic stroke.

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

HELSINKI, Finland—Adding IV tirofiban improves functional outcomes among patients undergoing systemic thrombolysis for acute ischemic stroke within 4.5 hours of symptom onset, results from the ...

Lumosa Therapeutics (Lumosa; 6535.TWO) and CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke. This new drug combines ...

Longer PTR times during thrombectomy significantly increase the likelihood of death or hospice discharge and raise acute stroke care costs.

Stroke is the leading cause of long-term disability and preventable disability in the United States. It is also the fifth leading cause of death, killing nearly 130,000 people in the U.S. each year.

New research has found that music therapy sessions have a positive effect on the neurorehabilitation of acute stroke patients, as well as their mood. New research has found that music therapy sessions ...

Adding oral anticoagulants (OACs) to standard antiplatelet therapy did not reduce recurrence in patients with acute ischaemic stroke (AIS) and no indication for oral anticoagulation; however, this ...

A patient with blink-triggered visual tilt shows a cortical lesion that initially mimicked a peripheral vestibular disorder.

Controversial changes to Yeovil Hospital's stroke services will take effect in the spring of 2026, with more patients being sent to Taunton ...